Allergan settles Alzheimer's therapy lawsuit for $750 million

Allergan Plc would pay $750 million to settle a class action lawsuit from a group of direct purchasers of Alzheimer's disease therapy Namenda, the drugmaker said, in a resolution to the litigation that was set to face trial on Monday.

Source: Reuters: Health - October 28, 2019 Category: Consumer Health News Tags: healthNews Source Type: news